Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$329M |
| 2 |
HTZ
Hertz Global Holdings, Inc.
HTZ
|
+$318M |
| 3 |
Elevance Health
ELV
|
+$211M |
| 4 |
Humana
HUM
|
+$149M |
| 5 |
Universal Health Services
UHS
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$1.12B |
| 2 |
AbbVie
ABBV
|
+$416M |
| 3 |
Herc Holdings
HRI
|
+$365M |
| 4 |
Labcorp
LH
|
+$171M |
| 5 |
Flex
FLEX
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.98% |
| 2 | Communication Services | 11.74% |
| 3 | Materials | 7.75% |
| 4 | Technology | 6.93% |
| 5 | Industrials | 6.81% |
Similar funds
Glenview Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Glenview Capital Management held 59 positions worth $14B, down 1.1% from $14.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Glenview Capital Management withdrew a net $588M in Q3 2016, closing 9 positions and reducing 11 holdings. Its most notable exit was Monsanto Co, an estimated $1.12B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 51% a quarter earlier, followed by Communication Services and Materials.
Against the trend, Glenview Capital Management opened a new position in Hertz Global Holdings, Inc. worth $265M.
- Glenview Capital Management's largest Q3 2016 buy was Hertz Global Holdings, Inc.: 7,599,786 shares worth $265M.
- Glenview Capital Management added most to Paramount Global Class B in Q3 2016, an estimated $329M increase.
- Glenview Capital Management's biggest Q3 2016 reduction was AbbVie, cutting an estimated $416M.
- Glenview Capital Management fully exited Monsanto Co in Q3 2016, selling an estimated $1.12B.
- Glenview Capital Management's ten largest holdings make up 55% of its $14B portfolio in Q3 2016.
- Glenview Capital Management opened 12 new positions and closed 9 in Q3 2016.
- Glenview Capital Management's portfolio value fell 1.1% quarter-over-quarter to $14B.
Based on Glenview Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.